ABBV vs JNJ: Side-by-Side Comparison
Compare Abbvie Inc (ABBV) and Johnson & Johnson (JNJ) side by side: market cap USD 461.26B vs USD 633.19B, P/E 128.8 vs 30.4. Financials, growth and model signals on Bullrun.
| Metric | ABBV | JNJ |
|---|---|---|
| Company | Abbvie Inc | Johnson & Johnson |
| Country / Exchange | United States · NYSE | United States · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-General | Drug Manufacturers-General |
| Market cap | USD 461.26B | USD 633.19B |
| P/E ratio | 128.8 | 30.4 |
| Dividend yield | 2.58% | 1.99% |
| Valuation model | 66.8% overvalued | 3.0% undervalued |
| Revenue (FY2025) | USD 61.16B | USD 94.19B |
| Revenue growth YoY | +8.6% | +6.0% |
| Net income | USD 4.23B | USD 26.80B |
| Gross margin | 70.2% | 67.9% |
| Diluted EPS | 2.36 | 11.03 |